June 23, 2017 6:17 PM ET

Healthcare Equipment and Supplies

Company Overview of Abingdon Health Ltd.

Company Overview

Abingdon Health Ltd., a medical diagnostics company, engages in developing, manufacturing, and commercializing point of care immunoassay tests for disorders of the immune system. The company offers medical diagnostics to clinics and laboratories, which include Seralite – FLC, a diagnostic device for test for the quantitative measurement of kappa and lambda immunoglobulin free light chains (FLCs) in serum and urine, as well as to aid in the diagnosis and management of multiple myeloma. It also provides contract services in the areas of lateral flow assay development and manufacture, reader systems, and quality standard. The company sells its products through distributors in Europe. Abingdon H...

National Innovation Campus

Sand Hutton

York,  YO41 1LZ

United Kingdom

Founded in 2008

Phone:

44 1904 406 082

Fax:

44 1904 462 122

Key Executives for Abingdon Health Ltd.

Chief Executive Officer
Age: 42
Finance Director
Operations Director
Chief Technology Officer
QARA Director
Compensation as of Fiscal Year 2016.

Abingdon Health Ltd. Key Developments

Abingdon Health Ltd. Announces Executive Changes

Abingdon Health Ltd. announced the appointment of Dr. David Pritchard as Chief Technology Officer. David has a track record of success within the medical diagnostics industry having spent the last twenty years at Axis-Shield Diagnostics, most recently as Head of Research. At Axis-Shield David was responsible for a Research and Development (R&D) team of 50 staff involved in the identification, evaluation, development and commercialisation of novel and challenging immunoassays. David is a member of the Industrial Advisory Group of the Institute of Bio-Sensing Technology. David will be responsible for the Group’s lateral flow immunoassay and reader development programmes based at the Group’s Birmingham site including the management of the Group’s development of the next generation lateral flow biosensor system in partnership with Sumitomo Chemical Corporation. David will be a member of the Group’s Executive Team and will report into Chris Yates, CEO. Dene Baldwin, current Technical Director, has decided to retire but will continue to work with Abingdon Health going forward in a consultancy capacity.

Abingdon Health Ltd Appoints Chris Yates as CEO

Imperial Innovations Group plc has led a £3.0 million investment in Abingdon Health Ltd. alongside existing investors. In conjunction with the investment round, Abingdon Health has appointed Chris Yates as CEO. Chris was previously CFO of Immunodiagnostic Systems Holdings PLC and Cozart plc.

Similar Private Companies By Industry

Company Name Region
11 Health Limited Europe
A. Algeo Limited Europe
Abingdon Health Ltd. Europe
Accentus Medical Ltd. Europe
AccuNostics Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 11, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Abingdon Health Ltd., please visit www.abingdonhealth.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.